Manufacturing and supplying pharmaceutical formulations globally, with a focus on quality and innovation.
Annual revenue $922,699 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Dellwin Pharmaceuticals

Dellwin Pharmaceuticals is a company. Dellwin Pharmaceuticals offers products and services including Tablets and Capsules and Injections.

Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $922.7 K (USD)
    3197.55
    as on Mar 31, 2022
  • Net Profit
    $23.32 K (USD)
    4248.82
    as on Mar 31, 2022
  • EBITDA
    $13.52 K (USD)
    1466.6
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Dellwin Pharmaceuticals

Dellwin Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injections.

Product name locked
Category locked
Primary

Tablets and capsules are manufactured and supplied in various formulations to meet medical needs across different therapeutic segments.

Product name locked
Category locked
Locked

Injections, including liquid and dry forms, are produced and distributed for use in global markets to address a range of health conditions.

Funding Insights of Dellwin Pharmaceuticals

Premium access

Detailed funding history for Dellwin Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Dellwin Pharmaceuticals

Investments
Premium access

Investment portfolio details for Dellwin Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Dellwin Pharmaceuticals

Premium access

Detailed financials for Dellwin Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Dellwin Pharmaceuticals Comparisons

Dellwin Pharmaceuticals Primary company
Description
Manufacturing and supplying pharmaceutical formulations glob...
Location
-
Founded Year
-
Annual Revenue
$922.7 K (USD)
Net Profit
$23.32 K (USD)
EBITDA
$13.52 K (USD)
Employees
Not available
Premium access

Peer comparison for Dellwin Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Dellwin Pharmaceuticals

Premium access

Detailed competitors of Dellwin Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Dellwin Pharmaceuticals

Premium access

Complete news archive for Dellwin Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dellwin Pharmaceuticals

Annual revenue of Dellwin Pharmaceuticals is $922.7K as on Mar 31, 2022.

Dellwin Pharmaceuticals is acknowledged worldwide for providing a broad range of pharmaceutical formulations that address medical needs. Headquartered in Mumbai, India, it holds certifications such as WHO GMP, cGMP, and ISO 9001:2000, and operates in over 30 countries. Continuous research and development activities are conducted to innovate medicines, while quality control measures ensure products meet global standards. Strategic partnerships and manufacturing collaborations are utilized to penetrate new markets and enhance global presence by 2025, emphasizing cost-effective and safe solutions for patients.

Dellwin Pharmaceuticals offers Tablets and Capsules and Injections.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available